Latest Form S-1 Stories
HOUSTON, July 21, 2014 /PRNewswire/ -- Westlake Chemical Partners LP (the "Partnership"), a Westlake company, today announced the commencement of its initial public offering of 11,250,000
SAN DIEGO, July 14, 2014 /PRNewswire/ -- Otonomy, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and
FLINT, Mich., July 3, 2014 /PRNewswire/ -- Diplomat Pharmacy, Inc.
FREMONT, Calif., June 24, 2014 /PRNewswire/ -- Zosano Pharma Corporation (Zosano) announced today that it has filed a registration statement on Form S-1 with the U.S.
SAN DIEGO, June 23, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
SEATTLE, June 16, 2014 /PRNewswire/ -- Trupanion, Inc.
ST. PETERS, Mo., May 29, 2014 /PRNewswire/ -- SunEdison, Inc. ("SunEdison")(NYSE: SUNE) today announced that its yieldco subsidiary, TerraForm Power, Inc.
SANTA MONICA, Calif., May 19, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products
SANTA CLARA, Calif., May 1, 2014 /PRNewswire/ -- ProteinSimple announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to
HOUSTON, April 29, 2014 /PRNewswire/ -- Westlake Chemical Corporation ("Westlake") (NYSE: WLK) announced today that one of its wholly owned subsidiaries, Westlake Chemical Partners LP ("Chemical
- totally perplexed and mixed up.